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The chronic involvement of the afferent visual system in multiple sclerosis (MS) is a powerful
model to understand the temporal course and functional relevance of neurodegeneration
because it is very well distinguishable from neighboring structures and offers quantifiable
structural and functional metrics. Optical coherence tomography (OCT) of the retina and
diffusion tensor imaging (DTI)-based tractography of the optic radiation have proven to
provide sensitive markers for neurodegeneration of the visual pathway in MS.1,2 OCT-derived
neuroaxonal retinal damage, represented by thinning of the retinal nerve fiber layer (RNFL)
and ganglion cell/inner plexiform layer (GCIPL), has been reported in patients with MS with
a history of optic neuritis (ON) and—to a lesser extent—also independent of ON episodes.1
RNFL and GCIPL show strong associations with visual function in MS, especially with low-
contrast visual acuity.3 Both layer thicknesses are associated with brain atrophy: this association
being stronger in the eyes without a history of ON.3
DTI facilitates the reconstruction and analysis of white matter tracts and can thereby reveal
microstructural changes of the optic radiation as the most frequently affected white matter
pathway in MS.2 Although fractional anisotropy (FA) is considered as a marker of micro-
structural integrity, higher radial diffusivity (RD) can be caused by demyelination and axial
diffusivity (AD) changes are suggested to be associated with axonal damage.2
In this issue of Neurology® Neuroimmunology & Neuroinflammation, Pawlitzki et al.4 describe
retinal neuroaxonal loss and microstructural changes in the optic radiation in MS, using OCT
and DTI-based tractography. In this cross-sectional study, 17 patients with a history of a single
unilateral ON episode and a sex- and age-matched cohort of 11 patients without an ON episode
were included. Pawlitzki et al. found more retinal atrophy and microstructural damage of the
optic radiation in patients with a history of ON—measured by thinning of the RNFL and
GCIPL as well as FA, AD, and RD changes in the optic radiation. This clearly describes the
pronounced damage in the visual system after a single ON episode. Furthermore, by reporting
associations of RNFL and GCIPL thickness with DTI parameters, the study is an important
confirmation of long-term anterograde and retrograde neuroaxonal loss in the afferent visual
system. Interestingly, the thickness of the primary visual cortex was neither associated with
optic radiation DTI parameters nor with RNFL and GCIPL thinning.4
DTI and retinal atrophy have emerged as important outcome measures in clinical MS research.1
However, to widely implement OCT and DTI for the individual monitoring of disease pro-
gression and treatment response, we still lack important pathologic and technical considerations.
The great advantages of OCT parameters include the rigorous and uniform quality control
criteria, the reproducible correlation with visual function, and the measurability of even small
degrees of atrophy.1,5 However, there is evidence that the test-retest reliability is associated with
scan protocols, scan quality, rater bias, or physiologic variation of common OCT parameters6,7
while keeping in mind that OCT is not histopathology. Dead and nonfunctional ganglion cells
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might also have a volume effect; meanwhile, other cells such as
astrocytes could contribute to thickness measurements. There
is evidence that edema—associated with chronic
inflammation—occurs in the RNFL, one of the most common
OCT outcome parameters.8 Thus, the effect of pseudoatrophy,
as we know it from MRI-based brain volume measurements,
might also be present in the RNFL.
The same applies to DTI-based metrics.2 In contrast to OCT,
the protocols for DTI acquisition and postprocessing are still
very heterogeneous, which substantially limits the use of DTI
as a potential biomarker.2,9 Furthermore, the diffusion tensors
in the optic radiation are influenced by optic radiation lesions
and (Wallerian) neurodegeneration resulting from optic
nerve damage.2 So far, researchers have not succeeded in
untangling these effects. In addition, the study of Pawlitzki
et al.4 does not shed light on this enigma: the frequency of
lesions in the optic radiation is lower in the non-ON group,
and the extent of ON-independent visual pathway damage in
this cohort could not be evaluated because the study did not
include healthy controls.
The lack of normal reference values, confounded with the
wide range of physiologic variation, challenge the in-
terpretation of imaging markers and, thus, their application
for individualized monitoring in MS. In the future, improving
OCT- and DTI-based metrics and combining their applica-
tion with newer methods such as the volumetric analyses of
the lateral geniculate nucleus will implement a gapless as-
sessment of structure and function in the afferent visual sys-
tem and thereby new pathophysiologic insights.10 For
example, it is currently controversially discussed whether ON-
independent retinal atrophy in MS is a result of subclinical
ON episodes, ongoing widespread inflammation and de-
myelination, trans-synaptic retrograde neurodegeneration
from lesions in the white matter pathway or a primary retinal
degeneration. None of these hypotheses is mutually exclusive,
and each of these may partially contribute to our observation.
Closing the gap between these metrics by applying ongoing
methodical advancements of afferent visual system research in
longitudinal studies will expand our pathophysiologic un-
derstanding and the differentiation of normal and disease-
related neurodegeneration in the afferent visual system of
patients with MS.
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